SCHEMBL10163299

SCHEMBL10163299

COc1ccc(Br)c(C(=O)Nc2cccc3c(C4CC4)c(OC)c(OC)cc23)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
HSD17B10 Q99714 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 5/20 0.40
MAPT P10636 4/20 0.40
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP1A2 P05177 2/20 0.40
POLB P06746 1/20 0.40
PKM P14618 2/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP3A4 P08684 1/20 0.37
STAT1 P42224 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132687 0.92 SMN1; SMN2 (0.41) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL13283974 0.82 SMN1; SMN2 (0.45) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10163103 0.82 LMNA (0.43) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10161848 0.81 KDM4E (0.43) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10161769 0.80 ABCB1 (0.44) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10163138 0.79 KMT2A (0.41) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10162973 0.79 HTT (0.35) KDM4EALDH1A1MEN1KMT2ACYP2C19
SCHEMBL10163178 0.78 MAPT (0.42) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10163297 0.78 TUBB4A (0.42) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT
SCHEMBL10163172 0.77 ABCB1 (0.47) SMN1; SMN2HSD17B10L3MBTL1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH SMN1; SMN2 3202/4885HSD17B10 1744/4885L3MBTL1 2647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.